A phase 1, multicenter, open-label, dose-escalation study of SGN 2FF in patients with advanced solid tumors - Regional Cancer Care Associates LLC

Clinical Trials

A phase 1, multicenter, open-label, dose-escalation study of SGN 2FF in patients with advanced solid tumors

Type of Cancer

Warning: implode(): Invalid arguments passed in /home/region33/public_html/wp-content/themes/regionalcancercenter/single-clinical-trials.php on line 42
Locations
Sponsor
Seattle Genetics
Protocol Number
Seattle Genetics SGN2FF-001
Cancer Diagnosis
To Learn More Call
201-510-0910